- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07629739
Inspiring Seniors Towards Exercise Promotion - 2 (iSTEP-2)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kaetlin Marsh, MPH
- Phone Number: 404-544-2381
- Email: kaetlin.marsh@emory.edu
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30329
- Recruiting
- Emory University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults over 65 years old.
- Ambulatory without pain or the use of assisted walking devices.
- Able to speak and read English.
- Healthy enough to exercise at moderate intensity with or without medical clearance by a primary care physician.
- Living in the community for the duration of the study (9-10 months).
- Having a reliable means of transportation.
- Having a safe place at home or at a residential area (at least 6 feet by 6 feet of open space) for unsupervised exercise training.
- Being low-active (< 90 min/week of MAT and < 2 days/week of ST for the last 3 months).
Exclusion Criteria:
- Concurrent diagnosis of neurological disorder (e.g., dementia, Parkinson's disease, multiple sclerosis, etc.), determined by self-report on the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+).
- Known exercise contraindications (uncontrolled hypertension, joint problems, diabetes, metabolic conditions, etc.), determined by self-report on the PAR-Q+.
- Current or upcoming cancer treatment, determined by self-report on the PAR-Q+.
- Stroke or neural impairment in the past 6 months, as self-reported on the PAR-Q+.
- Hip/knee/spinal fracture or surgery in the past 6 months, determined by self-report on the ACSM Health Screening Questionnaire.
- Unable or unwilling to attend intervention classes, as determined by phone screening.
- Currently participating in any other exercise or fitness-related research study, determined by phone screening.
- Use of medications for cognitive impairment, as self-reported on the medication survey.
- Change in dosage of medications prescribed for anxiety or depression within the previous 6 months, determined by self-report on a medication form.
- Self-report regularly drinking > 14 alcoholic beverages a week or current illicit drug use, determined by self-report to screening surveys.
Cannot ambulate without a walker/cane, assessed in the American College of Sports Medicine (ACSM) Health Screening Questionnaire
• Having cognitive impairment, determined by the Montreal Cognitive Assessment (MoCA) BLIND < 17.
- Meet the threshold for clinical depression, determined by the Center for Epidemiological Studies Depression Scale Revised (CESD-R).
- Uncorrected hearing or visual impairments, self-reported on the Health History Questionnaire.
- Unable to understand the study procedure.
- One of the household members is participating in this study, as self-reported during phone screening.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise intervention with RAS (EX+RAS)
Participants will be randomized to an exercise intervention with RAS (EX+RAS) over 6 months, offering the exercise prescription to foster independent adherence to the Physical Activity guidelines (PAG) through the gradual withdrawal of supervised training.
This group will be provided with RAS playlists and trained to use them for their exercise sessions.
|
Supervised exercise sessions will be led by an exercise specialist at an open-floor gym.
All participants will be asked to attend a supervised group exercise session for moderate aerobic training (MAT) for 15-40 minutes/day and muscle-strengthening training (ST) for 15-20 minutes/day for 2 days/week for the first 3 months, while being encouraged to independently perform MAT on up to 3 more days/week.
Then, the same training session will be offered for 1 day/week for an additional 3 months while encouraging participants to independently perform ST on 1 more day of the week and MAT up to 4 more days of the week.
Participants will be instructed on set and track exercise goals, supplemented with a series of behavioral supports during the 6-month intervention and until a 2-month post-intervention follow-up.
|
|
Active Comparator: Exercise intervention without RAS (EX)
Participants will be randomized to an exercise intervention (EX) over 6 months, offering the same exercise prescription as the experimental group, to foster independent adherence to the PAG through the gradual withdrawal of supervised training.
This group will not be provided with any RAS playlists to accompany their exercise.
|
Supervised exercise sessions will be led by an exercise specialist at an open-floor gym.
All participants will be asked to attend a supervised group exercise session for moderate aerobic training (MAT) for 15-40 minutes/day and muscle-strengthening training (ST) for 15-20 minutes/day for 2 days/week for the first 3 months, while being encouraged to independently perform MAT on up to 3 more days/week.
Then, the same training session will be offered for 1 day/week for an additional 3 months while encouraging participants to independently perform ST on 1 more day of the week and MAT up to 4 more days of the week.
Participants will be instructed on set and track exercise goals, supplemented with a series of behavioral supports during the 6-month intervention and until a 2-month post-intervention follow-up.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weekly volume of light, moderate, and vigorous physical activity as assessed by ActiGraph
Time Frame: 7 consecutive days at Baseline (before the intervention) and during month 1, 2, 3, 4, 5, and 6 (during intervention) and month 8 (2 months post-intervention)
|
Duration, intensity, and frequency of physical activity will be assessed using a waist-worn accelerometer.
|
7 consecutive days at Baseline (before the intervention) and during month 1, 2, 3, 4, 5, and 6 (during intervention) and month 8 (2 months post-intervention)
|
|
Physical activity behaviors as assessed by an Exercise Log
Time Frame: During month 1, 2, 3, 4, 5, 6, 7 (during the intervention) and month 8 (2 months post - intervention until 2-month post-intervention)
|
Daily duration and types of physical activity will be self-reported on an exercise log.
|
During month 1, 2, 3, 4, 5, 6, 7 (during the intervention) and month 8 (2 months post - intervention until 2-month post-intervention)
|
|
The single-item Feeling Scale (FS)
Time Frame: For 3 days at Baseline (before the intervention), weekly during month 1, 2, 3, 4, 5, and 6 (during intervention), and for 3 days in month 8 (2 months post-intervention)
|
The single-item Feeling Scale (FS) will be used to measure affective responses to physical activity as assessed by Ecological Momentary Assessment (EMA).
How are you feeling right now? with 11-point rating scale scores ranging from -5 to +5, with labels -5 = very bad, -3 = bad, -1 = somewhat bad, 0 = neutral, +1 = somewhat good, +3 = good, and +5 = very good.
|
For 3 days at Baseline (before the intervention), weekly during month 1, 2, 3, 4, 5, and 6 (during intervention), and for 3 days in month 8 (2 months post-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Borg's Rating of Perceived Exertion (RPE) scale
Time Frame: For 3 days at Baseline (before the intervention), weekly during month 1, 2, 3, 4, 5, and 6 (during intervention), and for 3 days in month 8 (2 months post-intervention)
|
Borg's Rating of Perceived Exertion (RPE) scale will be used to assess perceived exertion during physical activity as assessed by Ecological Momentary Assessment (EMA).
Scores range from 6 to 20, with verbal anchors of 7 = very, very light, 9 = very light, 11 = fairly light, 13 = somewhat hard, 15 = hard, 17 = very hard, and 19 = very, very hard.
|
For 3 days at Baseline (before the intervention), weekly during month 1, 2, 3, 4, 5, and 6 (during intervention), and for 3 days in month 8 (2 months post-intervention)
|
|
Cognitive Change Index (CCI-12)
Time Frame: At pre-test (before the intervention) and 6 weeks post-intervention
|
The Cognitive Change Index (CCI-12) is a 12-item questionnaire assessing self or informant-perceived decline in episodic memory over the past 5 years.
It uses a 5-point Likert scale (1=no change, 5=much worse), with higher total scores (range 12-60) indicating greater perceived decline.
It acts as a marker for dementia risk, subjective cognitive decline (SCD), and early Alzheimer's.
The CCI-12 ranges from 12 to 60. Higher scores signify greater perceived decline.
|
At pre-test (before the intervention) and 6 weeks post-intervention
|
|
Behavioural Regulation in Exercise Questionnaire-3 (BREQ-3)
Time Frame: Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)
|
The Behavioural Regulation in Exercise Questionnaire-3 (BREQ-3) is a 19 to 24-item tool (commonly 23-24 items) used to assess motivation for physical activity based on Self-Determination Theory.
It measures six types of motivation, ranging from not at all motivated to intrinsically motivated,.
Likert Scale Range: 0 to 4 (0 = "Not true for me", 4 = "Very true for me").
Higher average scores (closer to 4) indicate that a particular regulation style is a strong reason for exercising.
|
Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)
|
|
Physical Activity Enjoyment Scale (PACES)
Time Frame: Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)
|
Physical Activity Enjoyment Scale (PACES) to assess affective attitude toward PA.
Self-reported affective states relative to physical activity.
The Physical Activity Enjoyment Scale has 18 items on a 7-point Likert scale, and the total score ranges from 18 to 126.
A total score of 63 can be used to distinguish between enjoyment (>63) and lack of enjoyment (<63).
|
Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)
|
|
Self-Efficacy for Exercise Scale (SEE)
Time Frame: Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)
|
Self-Efficacy for Exercise Scale (SEE) is a self-report tool used to measure an individual's confidence in their ability to perform exercises regularly (e.g., 3 times per week for 20+ minutes) despite common barriers. The scale consists of 9 items. Scale: Each item is rated on an 11-point Likert scale ranging from 0 (Not Confident) to 10 (Very Confident). Minimum Score: 0 (representing zero confidence). Maximum Score: 90 (representing maximum confidence). Total Score Calculation: The total score is calculated by summing the responses to all 9 items. A higher total score indicates higher self-efficacy for exercise. 0-30: Low self-efficacy (low confidence in overcoming barriers to exercise). 31-60: Moderate self-efficacy. 61-90: High self-efficacy (high confidence in maintaining an exercise routine). |
Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)
|
|
Barriers to Being Active survey (BBA)
Time Frame: Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)
|
The Barriers to Being Active (BBA) survey is a 21-item questionnaire developed by the Centers for Disease Control and Prevention (CDC) to identify personal obstacles to exercise.
It measures seven distinct categories of barriers, with each category containing 3 items.
Each of the 21 questions is rated on a 4-point Likert scale: Very likely (3 points), Somewhat likely (2 points), Somewhat unlikely (1 point), Very unlikely (0 points).
Since there are 3 questions per category, the minimum score is 0, and the maximum score is 9 per barrier.
The minimum total score is 0, and the maximum total score is 63 (21 items × 3 points).
Significant Barrier: A score of 5 or higher in any of the seven categories indicates that it is an important barrier to overcome.
Low Barrier: A score below 5 indicates the barrier is less significant.
|
Baseline (pre-intervention), and during month 3 and 6 (during intervention) and month 8 (2 months post-intervention)
|
|
Physical and Sedentary Behaviour Questionnaire (PASB-Q)
Time Frame: At pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
The Physical and Sedentary Behaviour Questionnaire (PASB-Q) is a tool used to assess an adult's typical weekly physical activity, muscle strengthening, and sedentary habits.
It is not a single standardized 0-100 score, but rather a questionnaire that measures specific behaviors and can be used to gauge whether an individual meets physical activity guidelines.
The questionnaire measures several aspects of physical activity.
There is no set "maximum" score, as it measures frequency and duration, but the "minimum" is 0. It calculates the total minutes of moderate-to-vigorous aerobic physical activity per week.
Minutes/day = Total Minutes/Week.
Interpretation: Higher minutes per week indicate higher activity levels.
|
At pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
RAND 36-item Health Survey (RAND-36)
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
RAND 36-item Health Survey (RAND-36) to assess health-related quality of life.
The RAND 36-Item Short-Form Health Survey Scale has 36 items for self-report, takes 10-15 minutes to complete, and measures health-related quality of life with a score ranging from 0 to 100, where 0 indicates the lowest possible health state (worst health), and 100 indicates the highest possible health state (best health).
Higher scores always represent better health status.
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire used to evaluate sleep quality over a one-month interval.
It measures seven components of sleep, with a total global score ranging from 0 to 21. Minimum Score: 0 (Indicates no difficulty/excellent sleep quality).Maximum Score: 21 (Indicates severe difficulties in all areas/very poor sleep quality).
Higher Score = Worse Sleep: A higher total score indicates poorer sleep quality.
Scoring of 5: "Good" sleeper (low level of sleep disturbance) and > 5: "Poor" sleeper (indicates significant, relevant sleep disturbances)
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
The Center for Epidemiologic Studies Depression Scale-Revised (CESD-R)
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
The Center for Epidemiologic Studies Depression Scale-Revised (CESD-R) is a 20-item self-report questionnaire designed to measure the frequency and severity of depressive symptoms over the past two weeks.
It is used to identify individuals who may need a further clinical evaluation for depression.
Minimum Score (0): Indicates that the individual experienced almost no depressive symptoms, or that symptoms were present for less than one day, over the past two weeks.
Maximum Score (80): Indicates high frequency and severity, suggesting all 20 symptoms were present nearly every day for the past two weeks.
Total Score Range: The CESD-R uses a 5-point scale (0 to 4 per item), resulting in a total range of 0 to 80.
A total score of >=16 or >= 17 generally indicates a risk for clinical depression or significant depressive symptoms.
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
NIH Toolbox Perceived Stress Scale (PSS).
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
The NIH Toolbox Perceived Stress Scale (PSS) is a 10-item self-report questionnaire designed to measure how unpredictable, uncontrollable, and overloaded a person finds their life to be over the past month. The PSS is part of the NIH Toolbox Emotion Battery. Minimum Score (0): Indicates no perceived stress. Maximum Score (40): Indicates very high perceived stress. Calculation: Responses are scored on a scale of 0 (Never) to 4 (Very Often). Four positive items are reversed (0=4, 1=3, 2=2, 3=1, 4=0) before summing all 10 items for a total score. 0-13 (Low Stress): Below-average stress, generally feel in control. 14-26 (Moderate Stress): Average stress level, manageable but may warrant attention. 27-40 (High Stress): Elevated, high stress, often associated with poorer health outcomes. |
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
Arterial fitness
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
Arterial fitness will be measured using a SphygmoCor system before and after the intervention.
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
Central aortic pressure
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
Central aortic pressures will be measured using a SphygmoCor system before and after the intervention.
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
Body Weight
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
Measurements will be taken using the InBody380 scan.
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
Skeletal muscle mass
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
Skeletal muscle mass will be measured using the InBody380 scan.
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
Body fat percentage
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
Body fat percentage (percent body fat) will be measured using the InBody380 scan.
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
Barcelona Music Reward Questionnaire (BMRQ) to assess music-related reward experiences
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
The Barcelona Music Reward Questionnaire (BMRQ) assesses music-related reward experiences. It consists of 20 items rated from 1 (completely disagree) to 5 (completely agree), with scores ranging from 0 to 100. Musical Anhedonia (Low): <= 65. These individuals derive little to no pleasure from music despite having normal hearing and cognitive function. Average/Normal Reward: 66 - 86. The majority of the population falls within this middle range. Hyperhedonia (High): >= 87. These individuals experience unusually strong emotional or physical responses to music. |
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
Sagittal abdominal diameter
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
Measurements will be taken using a standardized anthropometric protocol (abdominal caliper)
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
Waist, hip, and leg circumference
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
Measurements will be taken using a standardized anthropometric protocol (abdominal caliper)
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
Playlist Rating survey
Time Frame: During month 3 and 6 (during intervention) and 8 months (2 months post-intervention)
|
The auditory stimulation score is assessed using a 10-item custom-developed survey by the research team; this survey assesses the extent to which audio and video playlists motivate individuals in strength and aerobic training.
Items are scored on a Likert-based scale (1 = Strongly Disagree, 7 = Strongly Agree).
Scores are stratified by method of playlist administration (i.e., audio and video) and then summed, with higher scores representing a higher level of auditory stimulation.
The total score ranges from 5 to 35 for aerobic and strength training, with higher scores indicating greater auditory stimulation.
|
During month 3 and 6 (during intervention) and 8 months (2 months post-intervention)
|
|
10-meter walk tests to assess normal and brisk walking cadence
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
The 10-meter walk test (10MWT) assesses gait speed by timing a patient walking a 10-meter distance, usually within a 14-meter path to allow for acceleration/deceleration. The test measures gait speed in m/s, with cadence (steps/min) calculated by counting steps during the timed trial.
It is a standardized assessment for gait.
Count the number of steps taken between the 2m and 12m markers during the timed, steady-state portion.
Studies show normal cadence is roughly 90 steps/min and brisk/fast cadence is roughly 140 steps/min.
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
The progress of aerobic capacity and endurance as assessed by 6-minute walk test
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
Hand Grip Strength
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
The squeeze power in pounds measured by a handheld dynamometer.
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
The progress of balance as assessed by 4-Stage Balance Test
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
The duration of maintaining 4 difference postures.
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
|
The progress of lower-body strength as assessed by 30-Second Sit-to-Stand test
Time Frame: At pre-test (before the intervention) and post-test, within 6 weeks after the intervention
|
The number of sit-to-stand maneuvers completed in 30 seconds.
|
At pre-test (before the intervention) and post-test, within 6 weeks after the intervention
|
|
The progress of balance, sit-to-stand, and walking as assessed by Timed Up and Go test
Time Frame: Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
The time taken to complete a Timed Up and Go test is an indicator of fall risks.
|
Pre-test (before the intervention) and post-test within 6 weeks after the intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kyoung Shin Park, PhD, Emory University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025P011936
- R33AG084479 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Data will be shared with anyone who registers with the repository and agrees to its Terms of Use, which limit data use to scientific research and aggregate statistical reporting, prohibit attempts to re-identify study participants, and prohibit redistribution of downloaded data.
Data will be shared for any scientific research or aggregate statistical reporting consistent with the Terms of Use.
Data will be deposited in UNC Dataverse, which assigns a DOI as a persistent identifier and provides searchable study-level metadata for discovery. The dataset will be available for direct download through the repository interface upon registration and acceptance of the Terms of Use.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Old Age
-
University of LisbonAssociacao Protectora dos Diabeticos de PortugalCompleted
-
Hallym University Kangnam Sacred Heart HospitalCompleted
-
National University of Ireland, Galway, IrelandIrish Research CouncilUnknown
-
Second Hospital of Shanxi Medical UniversityCompleted
-
McGill UniversityRéseau québécois de recherche sur le vieillissement; MUHC-Montreal General...Completed
-
Guangzhou Center for Disease Control and PreventionSouthern Medical University, ChinaRecruitingFall | Old AgeChina
-
Riphah International UniversityRecruitingFall | Old AgePakistan
-
Tabula Rasa HealthCareEnrolling by invitation
-
University Hospital, AngersWithdrawnSatisfaction | Old Age | UsabilityFrance
-
The Hong Kong Polytechnic UniversityCompletedOld Age | Family MembersHong Kong
Clinical Trials on Exercise intervention with RAS (EX+RAS)
-
American Scitech InternationalProactive Clinical ResearchUnknownType II Diabetes MellitusUnited States, India
-
The Hong Kong Polytechnic UniversityCompletedParkinson Disease | Movement, Abnormal | Bradykinesia | Acoustic Stimulation | ArmChina
-
Foundation University IslamabadCompleted
-
The Cleveland ClinicNational Institutes of Health (NIH)WithdrawnGait Disturbance in Multiple Sclerosis PatientsUnited States
-
University Hospital, Clermont-FerrandAME2P Laboratory, Clermont Auvergne UniversityCompleted
-
Chulalongkorn UniversityCompletedSmoking Cessation | Smoker LungThailand
-
University Hospital, Clermont-FerrandUniversité d'Auvergne; Tza Nou - Maison médicale pour enfants et adolescentes... and other collaboratorsCompleted
-
University of PittsburghUniversity of Pittsburgh Medical CenterRecruitingObesity | Muscle Composition | Quality of Life (QOL)United States
-
Tropical Diseases Research Centre, ZambiaUniversiteit Antwerpen; Medicines for Malaria Venture; National Institute for... and other collaboratorsEnrolling by invitationSevere MalariaZambia, Democratic Republic of the Congo
-
Institute of Hematology & Blood Diseases Hospital...RecruitingConnective Tissue Diseases | Autoantibodies | Immune Thrombocytopenia (ITP) | Evan SyndromeChina